Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells

GONG Yiqing; MENG Nana

doi:10.7619/jcmp.20211983

Journal of Clinical Medicine in Practice > 2021 > 25(20): 28-32. > DOI: 10.7619/jcmp.20211983

GONG Yiqing, MENG Nana. Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 28-32. DOI: 10.7619/jcmp.20211983

Citation:

PDF (852 KB)

Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells

Ophthalmology Department, the Affiliated People's Hospital of Jiangsu University, Zhenjiang First People's Hospital, Zhenjiang, Jiangsu, 212002

More Information

Received Date: May 11, 2021
Available Online: November 15, 2021
Published Date: October 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the effect and mechanism of erythropoietin(EPO)on light-induced retinal damage in Müller cells.
Methods Primary Müller cells of mice cultured were selected and divided into ultraviolet free group (control group) and ultraviolet group, each group was treated with different concentrations of EPO. The 3-(4, 5-demethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to detect cell viability. Western blot was used to detect the rotein kinase B(Akt) levels in EPO-activated Müller cells. Müller cells were divided into dimethyl sulfoxide (DMSO) control group(DMSO group)and inhibitors of Akt MK-2206 group(MK-2206 group). The above cells were treated in three ways: ① no ultraviolet group without treatment; ② ultraviolet group with ultraviolet radiation (30 mJ/cm2) for 30 min; ③ ultraviolet + drug group[the cells were pretreated with 1 μg/mL EPO for 30 min, and then treated with ultraviolet (30 mJ/cm²) radiation for 30 min]. The cell viability was detected by MTT. A total of 24 mice were divided into four groups: no injection group (right eye of mice, n=6), injection group (left eye of mice, n=6), illumination group (no injection eye receiving illumination, n=6) and illumination + injection group (injection eye receiving illumination, n=6). The mice in each group were examined by flash electroretinogram to assess impaired visual function.
Results Optical density (OD) values of cells pretreated with different concentrations of EPO in the ultraviolet group showed significant differences compared with those in the no ultraviolet group (P < 0.05). Compared with untreated cells, OD values of pretreated cells by EPO (0.1, 1, 10 μg/mL) were significantly increased by MTT (P < 0.01). The protective effect of Müller cells induced by EPO was also enhanced with the increase of EPO concentration (0.1 and 1 μg/mL, respectively, P < 0.05), while the protective effects of 1 and 10 μg/mL treatments showed no statistically significant differences (P=0.114). After Müller cells were treated with EPO (0, 0.1, 1, 10 μg/mL) for 1 h, western blot analysis showed that the protein expression levels of p-Akt (Ser-473) and Akt1 increased, and there was concentration dependence in the range of 0.1 and 1 μg/mL. There was no significant difference in amplitude between non-injection group and injection group (P=0.17). There were statistically significant differences in amplitude between the no injection group and injection group(P=0.17). There were statistically significant differences in amplitude between the no injection group and the illumination group, the illumination + injection group (P < 0.05). The amplitude of illumination + injection group showed significant difference compared with the illumination group (P < 0.05).
Conclusion EPO alleviates retinal light damage in mice by activating Müller cell Akt signaling pathway.
- erythropoietin,
- Müller cell,
- light damage,
- signal pathway

FullText(HTML)

References (19)

References

[1]	ZHOU Z W, LI F, ZHENG Z T, et al. Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury[J]. Brain Behav, 2017, 7(11): e00827. doi: 10.1002/brb3.827
[2]	ANDREAS REICHENBACH, ANDREAS BRINGMANN. Glia of the human retina[J]. Glia, 2020, 68(4): 768-796. doi: 10.1002/glia.23727
[3]	MARQUARDT T, GRUSS P. Generating neuronal diversity in the Retina: one for nearly all[J]. Trends Neurosci, 2002, 25(1): 32-38. doi: 10.1016/S0166-2236(00)02028-2
[4]	HERNÁNDEZ C, FONOLLOSA A, GARCÍA-RAMÍREZ M, et al. Erythropoietin is expressed in the human Retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema[J]. Diabetes Care, 2006, 29(9): 2028-2033. doi: 10.2337/dc06-0556
[5]	MARTI H H. Erythropoietin and the hypoxic brain[J]. J Exp Biol, 2004, 207: 3233-3242. doi: 10.1242/jeb.01049
[6]	WEISHAUPT J H, ROHDE G POLKING E, et al. Effect of erythropoietin axotomy-inducedapoptosis in rat retinal ganglion cells[J]. Invest Ophthalmol Vis Sci, 2004, 45(5): 1514-1522. doi: 10.1167/iovs.03-1039
[7]	FU Q L, WU W, WANG H, et al. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension[J]. Cell Mol Neurobiol, 2008, 28(2): 317-329. doi: 10.1007/s10571-007-9155-z
[8]	赵岩松, 赵堪兴, 王晓莉, 等. 低氧预适应对缺血再灌注损伤大鼠视网膜促红细胞生成素及活性caspase-3蛋白表达的影响[J]. 眼科新进展, 2013, 33(1): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201301004.htm
[9]	曲虹, 厉泉. 促红细胞生成素对高浓度葡萄糖培养大鼠视网膜Müller细胞的保护作用[J]. 中华临床医师杂志: 电子版, 2015, 9(14): 2722-2725. doi: 10.3877/cma.j.issn.1674-0785.2015.14.024
[10]	黄靖妍, 杨曦. rHEPO对大鼠急性视网膜光损伤的保护作用及时效性研究[J]. 北华大学学报: 自然科学版, 2016, 17(5): 628-631. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYY201605015.htm
[11]	LUO W, HU L, WANG F. The protective effect of erythropoietin on the Retina[J]. Ophthalmic Res, 2015, 53(2): 74-81. doi: 10.1159/000369885
[12]	ZHANG C, XIE H, YANG Q, et al. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin[J]. Clin Exp Ophthalmol, 2019, 47(9): 1182-1197. doi: 10.1111/ceo.13619
[13]	SONG G, OUYANG G, BAO S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med, 2005, 9(1): 59-71. doi: 10.1111/j.1582-4934.2005.tb00337.x
[14]	PAPADIMITRAKOPOULOU V. Development of PI3K/AKT/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer[J]. J Thorac Oncol, 2012, 7(8): 1315-1326. doi: 10.1097/JTO.0b013e31825493eb
[15]	LINDSLEY C W, ZHAO Z, LEISTER W H, et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors[J]. Bioorg Med Chem Lett, 2005, 15(3): 761-764. doi: 10.1016/j.bmcl.2004.11.011
[16]	SHIKUN HE, XIAOHUA LI, NYMPH CHAN, et al. Epigenetic mechanisms in ocular disease[J]. Mol Vis, 2013, 19(21): 665-674.
[17]	TAO Y, LI C, YAO A, et al. Intranasal administration of erythropoietin rescues the photoreceptors in degenerative Retina: a noninvasive method to deliver drugs to the eye[J]. Drug Deliv, 2019, 26(1): 78-88. doi: 10.1080/10717544.2018.1556361
[18]	HU L M, LUO Y, ZHANG J F, et al. EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells[J]. Front Biosci (Elite Ed), 2011, 1(3): 1541-1555.
[19]	TAN B, MACLELLAN B, MASON E, et al. Structural, functional and blood perfusion changes in the rat Retina associated with elevated intraocular pressure, measured simultaneously with a combined OCT+ERG system[J]. PLoS One, 2018, 13(3): e0193592. doi: 10.1371/journal.pone.0193592

[1]	BAO Qingying, ZHANG Lingling, MA Songhua, CHEN Xiaobo, JIANG Zhi, JIANG Qiqun. Correlations between serum soluble growth stimulationgene 2 protein, brain natriuretic peptide and the degree of carotid atherosclerosis in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 70-74, 78. DOI: 10.7619/jcmp.20240200
[2]	JIANG Nengmei, GUAN Xinjuan, YANG Shezhen. Correlations of growth arrest specific 6 and C1q/TNF-related protein 4 with carotid atherosclerosis in patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 123-127. DOI: 10.7619/jcmp.20223211
[3]	WU Zhen, XU Yan, SU Wentao, WU Gangyong. Correlations of serum parathyroid hormone and 25 hydroxyvitamin D with glycolipid metabolism in patients with type 2 diabetes mellitus complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(17): 120-124. DOI: 10.7619/jcmp.20221479
[4]	CHEN Yuchi, LIU Qiang. Correlation between monocyte to high-density lipoprotein cholesterol ratio and carotid artery stenosis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 36-39. DOI: 10.7619/jcmp.20201217
[5]	SHI Guiwen. Risk factors of type 2 diabetes mellitus complicated with carotid atherosclerosis and analysis of neutrophil to lymphocyte ratio and platelets to lymphocyte ratio levels[J]. Journal of Clinical Medicine in Practice, 2018, (1): 27-30. DOI: 10.7619/jcmp.201801009
[6]	CHEN Ying. Influence of different doses of atorvastatin on carotid atherosclerosis and inflammatory factors in patients with cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2016, (5): 25-28. DOI: 10.7619/jcmp.201605008
[7]	GAO Lin. Correlation between blood pressure variability and carotid atherosclerosis in hypertensive patients[J]. Journal of Clinical Medicine in Practice, 2016, (3): 1-3. DOI: 10.7619/jcmp.201603001
[8]	GUO Yuyu, CHEN Yingchao, SUI Chunhua. Relationship between subclinical hypothyroidism and carotid artery atherosclerosis in type 2 diabetes mellitus patients[J]. Journal of Clinical Medicine in Practice, 2015, (19): 16-18. DOI: 10.7619/jcmp.201519005
[9]	WANG Yingxin, LI Ai. Difference of serum uric acid level in type 2 diabeticpatients with different gender and its correlation with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2015, (13): 8-11. DOI: 10.7619/jcmp.201513003
[10]	WANG Junjun, YU Chunjuan, DING Qilong, XING Ting. Correlation between serum high sensitivity C-reactive protein and atherosclerosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (5): 5-7. DOI: 10.7619/jcmp.201505002

Cited By

Cited by

Periodical cited type(9)

1.	宋俊迎，王琼，李凤德. 冠心病及冠状动脉病变严重程度的影响因素分析. 中西医结合心脑血管病杂志. 2024(18): 3402-3406 .
2.	罗德钦，刘婷婷，熊青，聂荣杰. CD147/MMP-9通路与2型糖尿病合并高血压患者发生颈动脉粥样硬化的关系. 南昌大学学报(医学版). 2023(02): 50-53+79 .
3.	李婷，崔荣荣. 2型糖尿病合并MIS患者心室重构与血清CysC水平的相关性分析. 临床医学研究与实践. 2022(34): 118-120 .
4.	杨青，仝海燕，高雪梅. 2型糖尿病患者血清胱抑素C、半乳糖凝集素3、人软骨糖蛋白39与颈动脉粥样硬化的相关性. 中国卫生工程学. 2022(06): 991-993+996 .
5.	陈鹏程. 高血压患者血脂水平与颈动脉内膜增厚的相关性分析. 慢性病学杂志. 2021(01): 69-70+73 .
6.	朱宗国，杨洪余，黄澜，谭旭斌，卞西杰，钟铠璟. 糖尿病患者血清microRNA-152表达水平与血脂代谢、胰岛素抵抗的相关性. 中国现代医学杂志. 2021(08): 1-6 .
7.	王庆，虞寒芬，陈萍. 2型糖尿病患者继发颈动脉粥样硬化的危险因素分析. 现代实用医学. 2021(07): 923-924 .
8.	岳军. 血清HDL-C、LDL-C对老年2型糖尿病患者动脉粥样硬化的评估分析. 心血管病防治知识. 2021(30): 3-5 .
9.	郎慧芳，李红梅. 血清小而密低密度脂蛋白胆固醇与2型糖尿病患者颈动脉病变严重程度的相关性. 中国医药指南. 2020(34): 22-24 .

Other cited types(0)

Get Citation

PDF

XML

Article views (261) PDF downloads (13) Cited by(9)

Turn off MathJax

Article Contents

Abstract

References

Effect and mechanism of erythropoietin on light-induced damage in retinal Müller cells